IN2014MU01100A - - Google Patents

Info

Publication number
IN2014MU01100A
IN2014MU01100A IN1100MU2014A IN2014MU01100A IN 2014MU01100 A IN2014MU01100 A IN 2014MU01100A IN 1100MU2014 A IN1100MU2014 A IN 1100MU2014A IN 2014MU01100 A IN2014MU01100 A IN 2014MU01100A
Authority
IN
India
Prior art keywords
present disclosure
salmonella
relates
colonization
delivery vehicle
Prior art date
Application number
Other languages
English (en)
Inventor
Sambuddha Ghosh
Sanjiban Kumar Banerjee
Manisha Pravin Sabnis
Original Assignee
Sambuddha Ghosh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sambuddha Ghosh filed Critical Sambuddha Ghosh
Priority to MX2016012597A priority Critical patent/MX380349B/es
Priority to CA2943903A priority patent/CA2943903C/en
Priority to PCT/IB2015/000407 priority patent/WO2015145250A2/en
Priority to MYPI2016001742A priority patent/MY199990A/en
Priority to US15/129,661 priority patent/US10544208B2/en
Priority to AU2015237933A priority patent/AU2015237933B2/en
Priority to IN1100MU2014 priority patent/IN2014MU01100A/en
Priority to EP15727063.8A priority patent/EP3122773B1/en
Priority to BR112016022375-6A priority patent/BR112016022375B1/pt
Priority to CN201580027972.2A priority patent/CN107074934B/zh
Priority to NZ725349A priority patent/NZ725349B2/en
Publication of IN2014MU01100A publication Critical patent/IN2014MU01100A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1235—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Salmonella (G)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/005—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
IN1100MU2014 2014-03-27 2015-03-27 IN2014MU01100A (enrdf_load_stackoverflow)

Priority Applications (11)

Application Number Priority Date Filing Date Title
MX2016012597A MX380349B (es) 2014-03-27 2015-03-27 Expresion de un anticuerpo de cadena sencilla contra la salmonella en lactobacillus
CA2943903A CA2943903C (en) 2014-03-27 2015-03-27 Expression of a single chain antibody against salmonella in lactobacillus
PCT/IB2015/000407 WO2015145250A2 (en) 2014-03-27 2015-03-27 Expression of a single chain antibody against salmonella in lactobacillus
MYPI2016001742A MY199990A (en) 2014-03-27 2015-03-27 Expression of a single chain antibody against salmonella in lactobacillus
US15/129,661 US10544208B2 (en) 2014-03-27 2015-03-27 Expression of a single chain antibody against Salmonella in Lactobacillus
AU2015237933A AU2015237933B2 (en) 2014-03-27 2015-03-27 Expression of a single chain antibody against Salmonella in Lactobacillus
IN1100MU2014 IN2014MU01100A (enrdf_load_stackoverflow) 2014-03-27 2015-03-27
EP15727063.8A EP3122773B1 (en) 2014-03-27 2015-03-27 Expression of a single chain antibody against salmonella in lactobacillus
BR112016022375-6A BR112016022375B1 (pt) 2014-03-27 2015-03-27 Expressão de um anticorpo de cadeia única contra salmonella em lactobacillus
CN201580027972.2A CN107074934B (zh) 2014-03-27 2015-03-27 在乳杆菌中表达针对沙门氏菌的单链抗体
NZ725349A NZ725349B2 (en) 2015-03-27 Expression of a single chain antibody against salmonella in lactobacillus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1100MU2014 IN2014MU01100A (enrdf_load_stackoverflow) 2014-03-27 2015-03-27

Publications (1)

Publication Number Publication Date
IN2014MU01100A true IN2014MU01100A (enrdf_load_stackoverflow) 2015-10-02

Family

ID=54196512

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1100MU2014 IN2014MU01100A (enrdf_load_stackoverflow) 2014-03-27 2015-03-27

Country Status (9)

Country Link
US (1) US10544208B2 (enrdf_load_stackoverflow)
EP (1) EP3122773B1 (enrdf_load_stackoverflow)
CN (1) CN107074934B (enrdf_load_stackoverflow)
AU (1) AU2015237933B2 (enrdf_load_stackoverflow)
CA (1) CA2943903C (enrdf_load_stackoverflow)
IN (1) IN2014MU01100A (enrdf_load_stackoverflow)
MX (1) MX380349B (enrdf_load_stackoverflow)
MY (1) MY199990A (enrdf_load_stackoverflow)
WO (1) WO2015145250A2 (enrdf_load_stackoverflow)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10544208B2 (en) 2014-03-27 2020-01-28 Sambuddha Ghosh Expression of a single chain antibody against Salmonella in Lactobacillus
US10421806B2 (en) * 2015-02-04 2019-09-24 Abcelex Technologies Inc. Anti-salmonella antibodies and uses thereof
WO2017199094A1 (en) * 2016-05-20 2017-11-23 Novobind Livestock Therapeutics Inc. Antibodies against microorganisms and uses thereof
MX2020013248A (es) * 2018-06-05 2021-04-13 Novobind Livestock Therapeutics Inc Anticuerpos contra agentes patogenos en acuacultura y sus aplicaciones.
CN108864281B (zh) * 2018-07-13 2020-09-08 西北农林科技大学 一种抗肠炎沙门氏菌的纳米抗体及其应用
WO2020099922A1 (en) 2018-11-13 2020-05-22 Novobind Livestock Therapeutics, Inc. Antibodies against disease causing agents of canines and felines and uses thereof
US20230309601A1 (en) * 2020-07-06 2023-10-05 Singapore University Of Technology And Design 3d printing of milk-based product
CN113564095B (zh) * 2021-07-27 2023-10-20 陈玉松 外源核苷酸在促进干酪乳杆菌拮抗肠沙门氏菌方面的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100388A (en) 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
WO2003096812A1 (en) * 2002-04-15 2003-11-27 Washington University Regulated attenuation of live vaccines to enhance cross protective immunogenicity
CN101128182B (zh) 2004-11-25 2011-11-16 荷兰联合利华有限公司 重链和结构域抗体
ZA200800978B (en) 2005-08-19 2009-08-26 Unilever Plc Food products comprising probiotic micro-organisms and antibodies
CN101469333B (zh) * 2007-12-25 2014-01-22 温州医学院 一种抗沙门菌单链抗体与跨膜蛋白融合蛋白的制备方法
GB0816462D0 (en) * 2008-09-09 2008-10-15 Univ Birmingham Non-typoidal salmonella vaccines
US10544208B2 (en) 2014-03-27 2020-01-28 Sambuddha Ghosh Expression of a single chain antibody against Salmonella in Lactobacillus

Also Published As

Publication number Publication date
AU2015237933B2 (en) 2020-09-17
EP3122773A2 (en) 2017-02-01
WO2015145250A3 (en) 2016-01-21
MX380349B (es) 2025-03-12
CN107074934B (zh) 2021-06-29
US10544208B2 (en) 2020-01-28
NZ725349A (en) 2024-05-31
MX2016012597A (es) 2017-04-27
CA2943903C (en) 2023-03-14
US20170152305A1 (en) 2017-06-01
CN107074934A (zh) 2017-08-18
WO2015145250A2 (en) 2015-10-01
EP3122773B1 (en) 2020-07-22
AU2015237933A1 (en) 2016-10-20
CA2943903A1 (en) 2015-10-01
BR112016022375A2 (pt) 2019-01-15
MY199990A (en) 2023-12-02

Similar Documents

Publication Publication Date Title
IN2014MU01100A (enrdf_load_stackoverflow)
PH12016501763B1 (en) Multispecific antibodies
MX370807B (es) Anticuerpos que se unen a axl.
EP3604535A3 (en) Methods and compositions for weed control
PL2937424T3 (pl) Bakteria kwasu mlekowego, kompozycja ją zawierająca i ich zastosowanie
MX2016014862A (es) Her3 / her2 anticuerpos biespecificos que se unen a la horquilla beta de her3 y al dominio ii de her2.
EP3132022A4 (en) Synthetic methanotrophic and methylotrophic microorganisms
ZA201608394B (en) Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms
EP4382535A3 (en) Compositions and methods for targeted cytokine delivery
MY179341A (en) Method for producing l-amino acids using an alkaliphilic bacteria
EP3102207A4 (en) 2,4,5-tri-substituted azole-based casein kinase 1 inhibitors as inducers for cardiomyogenesis
PT3084009T (pt) Lactobacillus salivarius para o tratamento da mastite
EP3165599A4 (en) Novel lactic acid bacterium and composition including said lactic acid bacterium
MX2015017638A (es) Polioles que contienen tanino, su producción y su uso.
MX2016014416A (es) Anticuerpos anti-her3 que se unen a la horquilla beta de her3.
NZ730092A (en) Use of cysteamine in treating infections caused by yeasts/moulds
MX2015010023A (es) Anticuerpos anti-cd83 y su uso.
MX2019006090A (es) Metodos para mejorar la respuesta inmune con everolimus, dactolisib o ambos.
MY184391A (en) Microorganism having improved intracellular energy level and method for producing l-amino acid using same
PL3049102T3 (pl) Laktoferyna do leczenia IBD związanych z inwazją bakteryjną
PH12019550209A1 (en) A nutritional composition for use to enhance attention and/or reduce impulsivity
EP3153575A4 (en) Microorganism having ability to produce o-succinylhomoserine or succinic acid, and method for producing succinic acid or o-succinylhomoserine by using same
MX2016013363A (es) Metodo para aumentar la capacidad de sintesis de biomasa de microorganismos y microorganismos modificados a partir de ellos.
MY168632A (en) Growth promoting biofertiliser
TW201613850A (en) Method for preparation of trifluoroacetylacetic acid